Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Cholesterol emboli syndrome natural history, complications and prognosis
Introduction
Overview
Overview
Common complications of Cholesterol emboli syndrome include atheroembolic renal disease, acute kidney injury, chronic kidney disease, myocardial infarction, cerebrovascular accident bowel ischemia, liver failure, end organ damage and death. Prognosis is generally poor, and the incidence of mortality among patients with Cholesterol emboli syndrome is approximately 63-80Â %.
Natural History, Complications and Prognosis
Natural History, Complications and Prognosis
- Common complications of Cholesterol emboli syndrome include atheroembolic renal disease, acute kidney injury, chronic kidney disease, myocardial infarction, cerebrovascular accident bowel ischemia, liver failure, end organ damage and death. [1][2]
- Prognosis is generally poor, and the incidence of mortality among patients with Cholesterol emboli syndrome is approximately 63-80Â %.[1][3]
References
References
- ↑ 1.0 1.1 Agrawal, Akanksha; Ziccardi, Mary Rodriguez; Witzke, Christian; Palacios, Igor; Rangaswami, Janani (2018). “Cholesterol embolization syndrome: An under-recognized entity in cardiovascular interventions”. Journal of Interventional Cardiology. 31 (3): 407–415. doi:10.1111/joic.12483. ISSN 0896-4327.
- ↑ Ozkok, Abdullah (2019). “
Cholesterol-embolization syndrome: current perspectives
“. Vascular Health and Risk Management. Volume 15: 209–220. doi:10.2147/VHRM.S175150. ISSN 1178-2048. - ↑ Fine, Michael J.; Kapoor, Wishwa; Falanga, Vincent (2016). “Cholesterol Crystal Embolization: A Review of 221 Cases in the English Literature”. Angiology. 38 (10): 769–784. doi:10.1177/000331978703801007. ISSN 0003-3197.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Nasrin Nikravangolsefid, MD-MPH [2]